Management of Netherton syndrome and hereditary angioedema with concurrent biologic therapy: a case report
Exploration of Asthma & Allergy · 08.05.2026 · 4
DOI: 10.37349/eaa.2026.1009125 ↗Kurz gefasst
Fallbericht in der Zeitschrift Exploration of Asthma & Allergy, online erschienen am 08.05.2026. Verfasst von Mario Bruno Guanti und 3 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Netherton syndrome (NS) is a rare autosomal recessive disorder caused by SPINK5 mutations, leading to impaired skin barrier function and severe atopic manifestations. Hereditary angioedema due to C1 inhibitor deficiency (HAE-C1-INH) is a rare autosomal dominant disorder characterised by recurrent bradykinin-mediated angioedema. Their coexistence has not previously been reported, and evidence on combined biologic therapy is lacking. We report a 30-year-old woman with confirmed NS and long-standing HAE-C1-INH presenting with severe pruritus, xerosis, widespread eczema, elevated IgE, eosinophilia, and trichorrhexis invaginata. Dupilumab was initiated to target T helper (Th)2-mediated inflammation. Due to persistent angioedema attacks despite prior prophylaxis, lanadelumab was introduced. Dupilumab improved eczema severity, hyperkeratosis, and hair abnormalities over 13 months. Lanadelumab reduced angioedema attacks by 88.50%, allowing dose spacing while maintaining disease control. No adverse effects or drug interactions were observed. This is the first reported case of NS and HAE-C1-INH successfully treated with dual biologic therapy. Targeting distinct immunological pathways simultaneously may represent an effective and safe strategy for complex rare disease phenotypes.
Zitieren
APA
Guanti, M. B., Sartorio, S., Rivi, M., & Zanichelli, A. (2026). Management of Netherton syndrome and hereditary angioedema with concurrent biologic therapy: a case report. Exploration of Asthma & Allergy, 4. https://doi.org/10.37349/eaa.2026.1009125
Vancouver
Guanti MB, Sartorio S, Rivi M, Zanichelli A. Management of Netherton syndrome and hereditary angioedema with concurrent biologic therapy: a case report. Exploration of Asthma & Allergy. 2026;4. doi:10.37349/eaa.2026.1009125
BibTeX
@article{Guanti2026,
author = {Guanti, Mario Bruno and Sartorio, Silvio and Rivi, Marco and Zanichelli, Andrea},
title = {Management of Netherton syndrome and hereditary angioedema with concurrent biologic therapy: a case report},
journal = {Exploration of Asthma & Allergy},
year = {2026},
volume = {4},
doi = {10.37349/eaa.2026.1009125}
}
EUVIMED